{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T15:06:49Z","timestamp":1769958409748,"version":"3.49.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T00:00:00Z","timestamp":1442361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10,1]]},"DOI":"10.1002\/ejhf.337","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T21:58:49Z","timestamp":1442440729000},"page":"991-993","source":"Crossref","is-referenced-by-count":5,"title":["Insulin Resistance in Heart Failure: Widening the Divide Between Reduced and Preserved Ejection Fraction?"],"prefix":"10.1093","volume":"17","author":[{"given":"Stephen J.","family":"Greene","sequence":"first","affiliation":[{"name":"Division of Cardiology, Duke University Medical Center , Durham, NC ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[{"name":"Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles , Los Angeles, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,9,16]]},"reference":[{"key":"2026011921101278700_ejhf337-bib-0001","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(14)61889-4","article-title":"The war against heart failure: the Lancet lecture","volume":"385","author":"Braunwald","year":"2015","journal-title":"Lancet"},{"key":"2026011921101278700_ejhf337-bib-0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"2026011921101278700_ejhf337-bib-0003","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011921101278700_ejhf337-bib-0004","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ahj.2004.04.019","article-title":"Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial","volume":"148","author":"Das","year":"2004","journal-title":"Am Heart J"},{"key":"2026011921101278700_ejhf337-bib-0005","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"2026011921101278700_ejhf337-bib-0006","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","author":"Mentz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026011921101278700_ejhf337-bib-0007","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchf.2014.08.004","article-title":"Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure","volume":"3","author":"Dei Cas","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026011921101278700_ejhf337-bib-0008","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1001\/jama.2014.4115","article-title":"Management of comorbid diabetes mellitus and worsening heart failure","volume":"311","author":"Khan","year":"2014","journal-title":"JAMA"},{"key":"2026011921101278700_ejhf337-bib-0009","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.317","article-title":"Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction","volume":"17","author":"Scherbakov","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026011921101278700_ejhf337-bib-0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","article-title":"Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure","volume":"46","author":"Doehner","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026011921101278700_ejhf337-bib-0011","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/hrt.2003.029652","article-title":"Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure","volume":"91","author":"Wisniacki","year":"2005","journal-title":"Heart"},{"key":"2026011921101278700_ejhf337-bib-0012","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10741-014-9425-z","article-title":"Critical appraisal of the obesity paradox in cardiovascular disease: how to manage patients with overweight in heart failure?","volume":"19","author":"Doehner","year":"2014","journal-title":"Heart Fail Rev"},{"key":"2026011921101278700_ejhf337-bib-0013","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","article-title":"Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial","volume":"4","author":"Haass","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026011921101278700_ejhf337-bib-0014","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.amjcard.2012.10.042","article-title":"Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial)","volume":"111","author":"Greene","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026011921101278700_ejhf337-bib-0015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2009.04.049","article-title":"Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes","volume":"54","author":"Aguilar","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026011921101278700_ejhf337-bib-0016","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Action to Control Cardiovascular Risk in Diabetes Study GROUP","year":"2008","journal-title":"N Engl J Med"},{"key":"2026011921101278700_ejhf337-bib-0017","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.337","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/17\/10\/991\/66422251\/eurjhf_17_10_991.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/17\/10\/991\/66422251\/eurjhf_17_10_991.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:10:44Z","timestamp":1768875044000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/17\/10\/991\/8426440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,16]]},"references-count":17,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,9,16]]},"published-print":{"date-parts":[[2015,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.337","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,10]]},"published":{"date-parts":[[2015,9,16]]}}}